4.6 Review

PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Hyperandrogenic Symptoms Are a Persistent Suffering in Midlife Women with PCOS; a Prospective Cohort Study in Sweden

Sofia Persson et al.

Summary: Polycystic ovary syndrome (PCOS) is a common endocrine disorder among women, and hyperandrogenism can cause psychological morbidity and impaired quality of life. This study aimed to investigate whether hyperandrogenism persists into midlife and its impact on quality of life.

BIOMEDICINES (2023)

Article Obstetrics & Gynecology

No difference in morbidity between perimenopausal women with PCOS with and without previous wedge resection

Maria Forslund et al.

Summary: The objective of this study was to compare the cardiovascular disease (CVD) risk factors in women with polycystic ovary syndrome (PCOS) who had or had not undergone ovarian wedge resection (WR). The results showed that there were no differences in CVD risk factors among perimenopausal women with PCOS, regardless of whether they had undergone WR surgery or not, and regardless of body weight.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2023)

Article Obstetrics & Gynecology

Health-Related Quality of Life in perimenopausal women with PCOS

Maria Forslund et al.

Summary: This study found no significant differences in Health-Related Quality of Life (HRQoL) between peri- and postmenopausal women with PCOS and age-matched controls.

CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY (2022)

Article Obstetrics & Gynecology

Morbidity and mortality in PCOS: A prospective follow-up up to a mean age above 80 years

Maria Forslund et al.

Summary: No evidence of increased all-cause mortality or CVD was found in women with PCOS. The elevated testosterone levels and CVD risk profile in PCOS present during perimenopause do not seem to be associated with increased CVD morbidity/mortality risk later in life.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2022)

Review Endocrinology & Metabolism

The impact of ageing and menopause in women with polycystic ovary syndrome

Nafiye Helvaci et al.

Summary: PCOS in women of reproductive age is associated with increased risk of diabetes and cardiometabolic diseases, but the risk seems to decrease with ageing. Limited data suggest that cardiometabolic profile does not further deteriorate in women with PCOS after menopause, and the risk of cardiovascular disease in ageing women with PCOS appears to be similar to those without PCOS.

CLINICAL ENDOCRINOLOGY (2022)

Editorial Material Obstetrics & Gynecology

Heart health in polycystic ovary syndrome: time to act on the data

Anuja Dokras

Summary: Polycystic ovary syndrome (PCOS) is associated with a high prevalence of cardiometabolic risk factors, which may lead to cardiovascular disease. Guidelines have recommended screening and management of cardiometabolic risk factors in women with PCOS.

FERTILITY AND STERILITY (2022)

Article Obstetrics & Gynecology

Women with polycystic ovary syndrome are burdened with multimorbidity and medication use independent of body mass index at late fertile age: A population-based cohort study

Linda Kujanpaa et al.

Summary: This population-based follow-up study found that women with polycystic ovary syndrome (PCOS) had increased risk of comorbidities, medication use, and healthcare service use, independent of body mass index. The study also identified specific diseases that were more prevalent in women with PCOS, such as migraine, hypertension, tendinitis, osteoarthritis, fractures, and endometriosis.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2022)

Article Endocrinology & Metabolism

Polycystic ovary syndrome and leukocyte telomere length: cross-sectional and longitudinal changes

Johanna Polonen et al.

Summary: This study found that women with polycystic ovary syndrome (PCOS) have a different rate of telomere attrition compared to a control group, which may affect their risk of age-related diseases.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)

Article Mathematical & Computational Biology

Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments

Luke A. McGuinness et al.

Summary: Despite the availability of numerous software options for evidence synthesis, there is currently no universal tool for generating figures to display and explore risk-of-bias assessments. However, tools such as the R programming environment and Shiny have made it easy to create new tools for producing evidence syntheses. The new tool robvis facilitates the rapid production of publication-quality risk-of-bias assessment figures and is available as an R package and web app.

RESEARCH SYNTHESIS METHODS (2021)

Article Endocrinology & Metabolism

Reproductive Hormones and Anthropometry: A Follow-Up of PCOS and Controls From Perimenopause to Older Than 80 Years

Maria Forslund et al.

Summary: The study found that women with PCOS aged 72 to 91 had lower FSH levels, remained clinically hyperandrogenic, and had similar FAI and body composition as controls. From perimenopausal age until the present age, levels of testosterone and FAI continued to decline in women with PCOS, while SHBG levels continued to increase with age.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Endocrinology & Metabolism

Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome

P. Falcetta et al.

Summary: The study found that the clinical features and metabolic abnormalities of PCOS women vary with age. Young PCOS women are more likely to have clinical and biochemical hyperandrogenism, while metabolic burden tends to increase with age. Furthermore, there is a stronger relationship between BMI and most metabolic outcomes, regardless of age.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)

Article Endocrinology & Metabolism

Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies

Panagiotis Anagnostis et al.

Summary: Although the exact risk of developing type 2 diabetes mellitus (T2DM) in women with polycystic ovary syndrome (PCOS) is unknown, studies suggest that women with PCOS have an increased risk of T2DM compared to non-PCOS women only if they are obese or overweight.

ENDOCRINE (2021)

Article Endocrinology & Metabolism

The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome

Cindy Meun et al.

CLINICAL ENDOCRINOLOGY (2020)

Article Endocrinology & Metabolism

Population-based Data at Ages 31 and 46 Show Decreased HRQoL and Life Satisfaction in Women with PCOS Symptoms

Salla Karjula et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Review Endocrinology & Metabolism

Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression

Mina Amiri et al.

REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2020)

Review Obstetrics & Gynecology

Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis

V Wekker et al.

HUMAN REPRODUCTION UPDATE (2020)

Article Obstetrics & Gynecology

Higher menopausal age but no differences in parity in women with polycystic ovary syndrome compared with controls

Maria Forslund et al.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2019)

Article Endocrinology & Metabolism

Self-Reported Polycystic Ovary Syndrome Is Associated With Hypertension: A Northern Finland Birth Cohort 1966 Study

Meri-Maija E. Ollila et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

Article Endocrinology & Metabolism

Androgens, Irregular Menses, and Risk of Diabetes and Coronary Artery Calcification in the Diabetes Prevention Program

Catherine Kim et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)

Article Endocrinology & Metabolism

Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women

Yasir S. Elhassan et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)

Article Endocrinology & Metabolism

High Androgens in Postmenopausal Women and the Risk for Atherosclerosis and Cardiovascular Disease: The Rotterdam Study

Cindy Meun et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)

Article Geriatrics & Gerontology

Variation in symptoms of depression and anxiety in midlife women by menopausal status

Stephanie Mulhall et al.

MATURITAS (2018)

Article Obstetrics & Gynecology

Association between polycystic ovary syndrome and hot flash presentation during the midlife period

Ophelia Yin et al.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2018)

Review Endocrinology & Metabolism

Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment

Hector F. Escobar-Morreale

NATURE REVIEWS ENDOCRINOLOGY (2018)

Article Obstetrics & Gynecology

Prediction of age at menopause in women with polycystic ovary syndrome

S. Minooee et al.

CLIMACTERIC (2018)

Article Obstetrics & Gynecology

High androgen levels protect against hypothyroidism

Johanna Schmidt et al.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2017)

Article Endocrinology & Metabolism

Psychological Distress Is More Prevalent in Fertile Age and Premenopausal Women With PCOS Symptoms: 15-Year Follow-Up

Salla Karjula et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)

Article Endocrinology & Metabolism

Cerebral white matter lesions and silent cerebral infarcts in postmenopausal women with polycystic ovary syndrome

Zhou Guoqing et al.

GYNECOLOGICAL ENDOCRINOLOGY (2016)

Article Obstetrics & Gynecology

Common diseases as determinants of menopausal age

Jingmei Li et al.

HUMAN REPRODUCTION (2016)

Article Endocrinology & Metabolism

Weight Gain and Dyslipidemia in Early Adulthood Associate With Polycystic Ovary Syndrome: Prospective Cohort Study

Meri-Maija E. Ollila et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)

Article Public, Environmental & Occupational Health

Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome

C. Noel Bairey Merz et al.

JOURNAL OF WOMENS HEALTH (2016)

Article Endocrinology & Metabolism

Metabolic profile in women with polycystic ovary syndrome across adult life

Barbara Echiburu et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2016)

Article Endocrinology & Metabolism

Referral bias in female functional hyperandrogenism and polycystic ovary syndrome

Manuel Luque-Ramirez et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)

Article Endocrinology & Metabolism

Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study

Pekka Pinola et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)

Article Endocrinology & Metabolism

MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenism after menopause

Marios C. Markopoulos et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)

Article Health Care Sciences & Services

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

Xiang Wan et al.

BMC MEDICAL RESEARCH METHODOLOGY (2014)

Article Endocrinology & Metabolism

Complement protein C3 and coronary artery calcium in middle-aged women with polycystic ovary syndrome and controls

Michelle L. Snyder et al.

GYNECOLOGICAL ENDOCRINOLOGY (2014)

Article Endocrinology & Metabolism

Hyperandrogenic Oligomenorrhea and Metabolic Risks Across Menopausal Transition

Alex J. Polotsky et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)

Article Medicine, General & Internal

Premature Aging of Cardiovascular/Platelet Function in Polycystic Ovarian Syndrome

Wai Ping A. Chan et al.

AMERICAN JOURNAL OF MEDICINE (2013)

Article Endocrinology & Metabolism

Risk of Cardiovascular Events in Mothers of Women with Polycystic Ovary Syndrome

Kai Cheang et al.

Endocrine Practice (2013)

Article Medicine, General & Internal

Influence of obesity on atherogenic dyslipidemia in women with polycystic ovary syndrome

Antonio Hernandez-Mijares et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Endocrinology & Metabolism

Lifecycle of Polycystic Ovary Syndrome (PCOS): From In Utero to Menopause

Corrine K. Welt et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)

Review Endocrinology & Metabolism

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications

Evanthia Diamanti-Kandarakis et al.

ENDOCRINE REVIEWS (2012)

Article Endocrinology & Metabolism

Relative Contributions of Oligomenorrhea and Hyperandrogenemia to the Risk of Metabolic Syndrome in Midlife Women

Alex J. Polotsky et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)

Article Endocrinology & Metabolism

Management of Postmenopausal Virilization

Macarena Alpanes et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)

Article Endocrinology & Metabolism

Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare

Ligia Gabrielli et al.

REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2012)

Review Obstetrics & Gynecology

Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis

Robert A. Wild et al.

FERTILITY AND STERILITY (2011)

Article Endocrinology & Metabolism

Hyperandrogenism in Women with Polycystic Ovary Syndrome Persists after Menopause

Marios C. Markopoulos et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)

Article Endocrinology & Metabolism

Cardiovascular Disease and Risk Factors in PCOS Women of Postmenopausal Age: A 21-Year Controlled Follow-Up Study

Johanna Schmidt et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)

Article Endocrinology & Metabolism

Unfavorable Hormonal, Metabolic, and Inflammatory Alterations Persist after Menopause in Women with PCOS

Johanna Puurunen et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)

Article Oncology

Hormone-related factors and gynecological conditions in relation to endometrial cancer risk

Antonella Zucchetto et al.

EUROPEAN JOURNAL OF CANCER PREVENTION (2009)

Editorial Material Obstetrics & Gynecology

Reduced serum ghrelin in a putative postmenopausal polycystic ovary syndrome phenotype

Andrew J. Krentz et al.

FERTILITY AND STERILITY (2009)

Article Endocrinology & Metabolism

Criteria for Polycystic Ovarian Morphology in Polycystic Ovary Syndrome as a Function of Age

S. Alsamarai et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)

Article Endocrinology & Metabolism

Adrenal Androgen Production Capacity Remains High up to Menopause in Women with Polycystic Ovary Syndrome

Johanna Puurunen et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)

Article Endocrinology & Metabolism

A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs

Hector F. Escobar-Morreale et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)

Article Endocrinology & Metabolism

Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome

Manuel Luque-Ramirez et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)

Article Obstetrics & Gynecology

Searching for polycystic ovary syndrome in postmenopausal women:: evidence of a dose-effect association with prevalent cardiovascular disease

Andrew J. Krentz et al.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2007)

Review Endocrinology & Metabolism

Abdominal adiposity and the polycystic ovary syndrome

Hector F. Escobar-Morreale et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)

Article Endocrinology & Metabolism

Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline

Ricardo Azziz et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)

Review Endocrinology & Metabolism

Human ovarian theca cells in culture

JK Wickenheisser et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)

Article Endocrinology & Metabolism

The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome

EO Talbott et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)

Review Endocrinology & Metabolism

Polycystic ovary syndrome and cardiovascular disease: A premature association?

RS Legro

ENDOCRINE REVIEWS (2003)

Article Obstetrics & Gynecology

Polycystic ovary syndrome and cancer

A Balen

HUMAN REPRODUCTION UPDATE (2001)

Article Hematology

Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women

EO Talbott et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)

Article Obstetrics & Gynecology

Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome

SJ Winters et al.

FERTILITY AND STERILITY (2000)